Objective: To examine the impact of nephrectomy delay on the survival of patients with small renal masses.
Methods: Relying on the Surveillance, Epidemiology, and End Results Medicare-linked database, 6,237 patients with pT1a renal cell carcinoma who underwent radical or partial nephrectomy were identified (1988-2005). Nephrectomy delay was dichotomized as ≤ 3 vs. >3 months. Uni- and multivariate Cox regression analyses tested the effect of delayed nephrectomy on cancer-specific mortality (CSM). In sub-analyses, various other time from diagnosis to nephrectomy cut-offs were modelled: (a) ≤ 1 vs. >1 month, (b) ≤ 2 vs. >2 months, (c) ≤ 4 vs. >4 months, (d) ≤ 6 vs. >6 months, (e) ≤ 12 vs. >12 months or (f) continuously coded.
Results: In univariate analyses, nephrectomy delay >3 months was associated with a higher risk of CSM (hazard ratio [HR]: 2.07; 95% confidence interval [CI]: 1.58-2.72; p < 0.001). However, after multivariate adjustment, a nephrectomy delay >3 months was not significantly associated with a higher risk of CSM (HR: 1.33; 95% CI: 0.96-1.86; p = 0.09). The lack of a relationship between nephrectomy delay and CSM after multivariate adjustment persisted even in various sub-analyses of other categorizations for nephrectomy delay.
Conclusions: In the case of eventual nephrectomy delay among patients with small renal masses, CSM is unaffected.
Written by:
Becker A, Roghmann F, Ravi P, Tian Z, Kluth LA, Gandaglia G, Noldus J, Dahlem R, Schlomm T, Graefen M, Karakiewicz PI, Trinh QD, Sun M. Are you the author?
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada.
Reference: Urol Int. 2014 Feb 28. Epub ahead of print.
doi: 10.1159/000356175
PubMed Abstract
PMID: 24602994
UroToday.com Renal Cancer Section
